The article discusses the historical aspect and modern ideas about the etiology and pathogenesis of progressive multifocal leukoencephalopathy in patients with HIV infection. An analysis and synthesis of literature data on the clinical presentation of this pathology was carried out. The possibilities and limitations of laboratory and instrumental diagnostic methods, including neuroimaging methods, are discussed in detail. The pathomorphological signs of the disease in HIV-positive individuals are covered.
13 March 2020 in Russian Journal of Spine Surgery (Khirurgiya Pozvonochnika)
Glioblastoma-related epilepsy requires paying careful attention to a combination of factors with an integrated approach. Major interrelated issues must be considered in the seizure care of glioblastoma patients. Seizure control frequently requires the administration of antiepileptic drugs simultaneously with other treatments, including surgery, radiotherapy and chemotherapy, with complete seizure relief often being difficult to achieve. The pharmacological interactions between antiepileptic drugs and antineoplastic agents can modify the activity of both treatments, compromising their efficacy and increasing the probability of developing adverse events related to both therapies. This review summarizes the new pathophysiological pathways involved in the epileptogenesis of glioblastoma-related seizures and the interactions between antiepileptic drugs and oncological treatment, paying special attention to its impact on survival and the current evidence of the antiepileptic treatment efficacy, including the potential usefulness of new third-generation compounds.
1 January 2021 in Journal of Ural Medical Academic Science
The adverse effect on the body of a number of factors of the external and internal environment contributes to the formation of free radicals (SR). An increase in the content of the latter can lead to a number of serious diseases, such as: bronchial asthma, diabetes mellitus, oncological diseases, premature aging of the body, etc. This will significantly increase the level of disability, and sometimes even mortality among the population. In this connection, the prevention of these pathologies is an urgent task of modern society. As an effective preventive means, we can recommend the antioxidant molecules (AO), which will be discussed in this article. The issues characterizing AO as biologically significant molecules are considered. The article presents: the concept of AO, their properties, mechanism of action, classification and functions; describes the areas of application and ways of influencing AO on the body. It is shown that AO, along with proteins, fats, carbohydrates, should be an integral part of the diet. The body needs a constant supply of AO, in order to maintain a balance between the interaction of the internal and external environment.
Epilepsy caused by glioblastoma requires careful study of the combination of factors causing it, with an integrated approach to prevention and complete relief when seizures occur against the background of adequate and modern treatment regimens. Control of seizures often requires the administration of antiepileptic drugs concomitantly with other treatments, including surgery, radiation, and chemotherapy. Pharmacological interactions between antiepileptic drugs and antineoplastic agents may alter the activity of both treatments, reducing their effectiveness and increasing the likelihood of side effects associated with both therapies. The presented literature review summarizes novel pathophysiological pathways associated with glioblastoma and involved in epileptogenesis, and also describes the interaction between antiepileptic drugs and oncological treatment. The article focuses on the impact of treatment on survival and presents evidence of the effectiveness of antiepileptic treatment, including the potential usefulness of new third-generation antiepileptic drugs. The second part of the article discusses in detail aspects of both preventive and symptomatic treatment of patients with epilepsy associated with glioblastomas.
1 January 2021 in Journal of Ural Medical Academic Science
Peptides are a class of organic substances consisting of two or more amino acid residues connected to each other by peptide bonds —C(O)NH—. Peptides were first mentioned in 1900 by the German organic chemist G. E. Fischer. He assumed that peptides consist of a chain of amino acids connected by a certain type of bond. In 1902, he was able to prove the presence of a peptide bond, and by 1905 he had developed a general method that allows synthesizing peptides in the laboratory. Friedrich Engels said the most succinctly about proteins: «Life is a way of existence of protein bodies...». It follows from this that if there are protein molecules, there is an organism’s life and, conversely, there are no proteins — the organism is not viable. Probably, this fact served as an incentive for further study of peptides. So, in the middle of the last century, an opinion appeared among scientists about a new class of chemically active substances-cytomedins (biologically active peptides, regulatory peptides, peptide bioregulators (PB)). These molecules will be discussed in this paper.